AGM/EGMJul 28, 2026, 05:02 PM
Telomir Pharmaceuticals to Hold Annual Meeting on September 11, 2026
AI Summary
Telomir Pharmaceuticals, Inc. announced its Annual Meeting of Shareholders will be held virtually on September 11, 2026. Shareholders will vote on the election of four directors, the ratification of Salberg & Company, P.A. as the independent registered public accounting firm for fiscal year 2026, and a proposal to adjourn the meeting if necessary. The Board of Directors recommends voting "FOR" all proposals.
Key Highlights
- Annual Meeting of Shareholders scheduled for September 11, 2026, at 11:00 a.m. Eastern Time.
- Meeting will be held exclusively online via live audio-only webcast.
- Shareholders will vote to elect four directors to the Board.
- Shareholders will vote to ratify Salberg & Company, P.A. as the independent auditor for fiscal year 2026.
- The Board recommends voting "FOR" all proposals.
- Record Date for voting is July 21, 2026, with 68,774,954 shares of Common Stock outstanding.
- Salberg & Company, P.A. billed $87,000 for audit fees and $18,000 for audit-related fees in 2025.
- Former auditor Cherry Bekaert LLP billed $64,000 for audit fees and $51,000 for audit-related fees in 2024.
Price Impact
More from TELO
More in AGM/EGM